Page 1



THE CITY OF STOCKHOLM WELCOMES THE 11TH ECE CONGRESS Dear Delegates, Stockholm is one of the world’s most popular cities for meetings of almost all sizes. Not least due to its proven record of organisation, infrastructure and typical Scandinavian attention to detail, flexibility and efficiency. Based on innovation and fuelled by high technology, the Stockholm region’s economy boasts one of the world’s most prominent information and communications technology clusters, one of Europe’s largest life sciences clusters and fast growing cleantech and fashion industries – to name but a few. The Capital of Sweden also presents an abundance of culture, attractions and worldrenowned entertainment. As a clear recognition of the fact that sustainability is continuing to be a top priority for Stockholm - Stockholm was awarded the “European Green Capital” in 2010. Reaching Stockholm is swift and simple regardless of where your journey starts. And while here you have a high speed connection from Stockholm-Arlanda Airport, and one of the most efficient and well-structured public transport systems in the world at your service - if you don’t just choose to walk around in this compact city. We hope you will enjoy Stockholm and that coming here will give you a feeling of the city and its many advantages as a destination for successful congresses such as the ECE congress. Yours sincerely, Henrik von Arnold Director Stockholm Convention Bureau






Kristina Malmgren (Sweden)

Meir Bialer (Israel)

Members Alla Guekht (Russia) Reetta Kälviäinen (Finland) Ivan Rektor (Czech Republic) Philip Smith (UK) Torbjörn Tomson (Sweden)


Torbjörn Tomson (Sweden) Members Meir Bialer (Israel) Milan Brádzil (Czech Republic) Helen Cross (UK) Reetta Kälviäinen (Finland) Merab Kokaia (Sweden) Kristina Malmgren (Sweden) Philippe Ryvlin (France) Simon Shorvon (UK) Federico Vigevano (Italy)



WELCOME LETTER FROM THE CO-CHAIRS OF THE INTERNATIONAL ORGANISING COMMITTEE Dear Colleagues, On behalf of the organising committee, we wish to invite you to attend the 11th European Congress on Epileptology (ECE) of the International League Against Epilepsy, in Stockholm on June 29th – July 3rd 2014. The Stockholm 2014 congress promises to be a very interesting and inspiring meeting. The programme will cover cutting-edge research in the field of epilepsy through presentations from key opinion leaders in the field, including lectures by world-renowned scientists on topics at the interfaces of epilepsy. The schedule will also feature a coordinated clinical teaching programme with a course on pharmacological treatment of epilepsy as well as a course for epilepsy nurses and EEG technicians. Four main themes run through the programme: the basic science main session theme has the exciting title Changing epileptic brain: translational challenges and opportunities.The main theme focusing on epilepsy surgery with the title Who benefits from epilepsy surgery? will be oriented towards patient outcomes; the paediatric main theme, with the title Epilepsy syndromes: from infancy to adulthood, spans the development as children grow into adults and, last but not least, the main theme on pharmacological treatment looks ahead: Pharmacotherapy of the future: new molecules, new targets, new goals. Parallel sessions, workshops and courses in these and other topics will be held. There will be a strong emphasis on high quality platform and poster presentations, and we invite you all to prepare your work for abstract submission. This promises to be a great congress. The London congress in 2012 gave us Nobel Lectures and the Stockholm congress will follow up on this with a lecture about the man behind the name – Alfred Nobel. Stockholm is a fascinating and beautiful city and the nights are short in summer. We hope that you will enjoy the congress as well as the city and the Nordic summer. We look forward to welcoming you to Stockholm! With warm regards, Kristina Malmgren

Meir Bialer

Co-Chair International Organising Committee

Co-Chair International Organising Committee



WELCOME FROM THE CHAIR OF THE SCIENTIFIC ADVISORY COMMITTEE Dear Colleagues, The Scientific Advisory Committee (SAC) has worked arduously to construct an exceptional programme for the Stockholm 2014 congress. Our aim has been to offer a programme that provides cutting-edge science as well as high quality teaching on topics of direct relevance to your everyday clinical practice. Indeed the scientific programme is intended to cover all aspects of epileptology, but four main themes have been selected representing basic science, epilepsy surgery, pharmacotherapy and paediatric epileptology. Each theme will be showcased in a main session namely “Changing epileptic brain: translational challenges and opportunities”, “Who benefits from epilepsy surgery?”, “Epilepsy syndromes: from infancy to adulthood” and “Pharmacotherapy of the future: new molecules, new targets, new goals”. These four main themes are also covered in additional related scientific sessions. One of the primary goals of the SAC for this congress is to increase the emphasis on high quality platform presentations by allocating more time to them given that they can often be the source of the latest scientific findings. Furthermore platform presentations provide an important opportunity for younger researchers to meet and engage in valuable discussions with their peers. Poster sessions will continue to be a significant part of the programme and we intend to give full attention to the posters with both guided tours and poster highlight sessions. Stockholm 2014 will build on the success of its predecessors. Many of the features introduced in London 2012 will be carried forward in Stockholm, some with a local twist. The London congress introduced lectures by selected Nobel Prize Laureates. Bringing the 11th ECE to the home town of Alfred Nobel, the Stockholm congress will follow up on the Nobel theme with a lecture about the man behind the Prize. We are also planning an exhibit of selected items from the Nobel Museum during the Welcome Ceremony. Additionally there will be a reception in the City Hall, the venue for the Nobel Prize banquet. ECE Forums were a great success in London. The Forums will be continued in Stockholm with the ambition to reserve the format for interactive discussions focusing on new topics or projects of special interest. However we are also introducing some new features; taking advantage of new technology we invite delegates to participate in a highly interactive session on the use of the proposed ILAE Classification and organisation of seizures and epilepsies. There will be an exciting joint symposium between the Commission on European Affairs (CEA) and the European Sleep Research Society entitled “Epileptic and non-epileptic sleep related paroxysmal motor events”. Epilepsy Advocacy Europe will present their achievements in a symposium with the title “A political agenda for supporting epilepsy care and research in Europe”. Two sessions have a special historical perspective: the session entitled “Unverricht-Lundborg Disease from 1891 to 2014” and the “Carbamazepine 50th Year Anniversary Symposium”. The popular Chairs’ Symposium will be dedicated to prevention in epileptology in its broadest sense. The meeting will conclude with a Congress Highlights session, where the main session chairs will summarise the most important advancements presented within their themes. As in London, the last day of the congress will be an ECE teaching day with a full day course on the “Pharmacological treatment of epilepsy” and two separate comprehensive courses targeting epilepsy nurses and EEG technicians.



In addition, teaching sessions will feature three attractive morning series run over three days: “The seizure semiology smörgåsbord” are didactic video sessions; “Found in translation: basic science explained” targets clinicians who want to better understand experimental epilepsy research; and lastly the What Not-to-Do series, taking a slightly different perspective than the previous highly appreciated How-to-Do series. Although we do everything in our power to create an attractive and packed scientific programme, we hope that you will find some time to enjoy Stockholm. The capital of Sweden has a history spanning more than 700 years. Spreading across 14 islands, Stockholm faces the Baltic Sea. June and July, when days are long and nights are bright, is the perfect time to enjoy this beautiful city and its surroundings including the unique and easily accessible archipelago of 30,000 islands. On behalf of the Scientific Advisory Committee, we look forward to welcoming you to the 11th European Congress on Epileptology next June and to the wonderful city of Stockholm. With best wishes, Torbjörn Tomson Chair Scientific Advisory Committee







SCIENTIFIC PROGRAMME INFORMATION SESSIONS The scientific sessions form the main part of the congress. The main topics were chosen by the International Organising Committee and the sessions were selected from the numerous proposals submitted by ILAE members and other experts. These sessions were selected to represent the best European and global epileptology. Our programme covers all aspects of epileptology, but four main themes have been selected. Each day has different themes representing basic science, epilepsy surgery, pharmacotherapy and paediatric epileptology. Each main theme features one plenary main topic session and four additional sessions. SPECIAL SYMPOSIA Special symposia include the Chairs’ Symposium, which this year is dedicated to Prevention in epileptology. The symposium will explore a number of important aspects of prevention, ranging from prevention of the development of epilepsy to prevention of the devastating consequences of epilepsy and its treatment. A second special symposium will update delegates on the achievements of the joint ILAE/IBE Task Force – Epilepsy Advocacy Europe, under the symposium title: A political agenda for supporting epilepsy care and research in Europe. The ILAE Commission on European Affairs (CEA) will also present a special symposium on the European perspective of regulatory issues with antiepileptic drugs. Another special symposium explores the borderland between epileptology and sleep medicine. This session on Epileptic and non-epileptic sleep-related paroxysmal motor events is a collaboration between CEA and the European Sleep Research Society. TEACHING SESSIONS / COURSES     


The seizure semiology smörgåsbord, with didactic video presentations, over 3 mornings. Found in translation: basic science explained is meant to be truly translational, as the series targets clinicians who wish to understand and learn more about basic science in epileptology, over 3 mornings. The What Not-to-Do series is a clinically oriented series of interactive morning seminars presenting red flags in the diagnosis and management of people with seizure disorders, over 3 mornings. ABC of epilepsy epidemiology will discuss basics in methodologies, for those who want to understand or engage in epidemiological research in one morning teaching session. Two morning teaching sessions will be dedicated to VIREPA courses.



The course on Pharmacological treatment of epilepsy will run from 08:00 to 15:00. It spans from basic mechanisms of actions of antiepileptic drugs and pharmacokinetics to pharmacological treatment in different clinical settings. Although the epileptologist delegate is the primary target, the course should also be useful for other neurologists and neuropaediatricians who take care of patients with epilepsy and who need an update from experts in the field. A second course, primarily aimed at epilepsy nurses, will run from 08.00 to 11.00 and a third course, for EEG technicians, will run from 11.30 to 13.00. Day registration will be available for those who wish to register just for these courses. All full registered delegates for the congress can attend the ECE teaching courses free of charge. ECE FORUMS The ECE Forums were an innovation in the scientific programme of the 10th ECE and, following on from their success, the innovative and popular ECE Forums will again form part of the programme for the 11th ECE. These Forums are designed to be sessions in which selected topics can be explored and discussed in an informal workshop or clubroom style. The topics will be selected from proposals submitted by members worldwide and will focus generally on cutting-edge or controversial aspects of epilepsy work, not least including discussions on new or planned projects of general interest. Priority will be given to new topics rather than the continuation of topics discussed in London. The sessions are intended to be creative and interactive and are free of charge to all participants of the congress. AWARDS SESSION The symposium of excellence in epileptology will include lectures presented by the recipients of the 2014 European Epileptology Award and the CEA Young Investigator Award. HIGHLIGHTS SESSION This concluding session is intended to give delegates an overview of the most important advancements that have been presented during the congress. Each main topic chair has been charged to summarise what they consider to be the highlights from presentations within their theme. PLATFORM AND POSTER PRESENTATIONS Special attention will be given to poster presentations during the 11th ECE. Researchers are invited to submit abstracts that will be reviewed by the Scientific Advisory Committee and considered for platform presentations, special poster sessions or poster tours. Please refer to the congress website for submission instructions.



SPECIAL SYMPOSIA CHAIRS’ SYMPOSIUM: PREVENTION IN EPILEPTOLOGY Prevention is a priority in health care today and epilepsy should be no exception. The 11th ECE Chairs’ Symposium is therefore dedicated to Prevention in epileptology. The symposium will explore prevention in its broadest sense. The first lectures will discuss the potential for prevention of epileptogenesis based on experimental as well as clinical data. The second part of the symposium will focus on aspects of prevention for people with established epilepsy, including prevention of adverse effects of treatment, prevention of the most devastating consequences of epilepsy, and prevention of adverse effects imposed by society, e.g. stigma.

Co-Chairs: Meir Bialer (Israel), Kristina Malmgren (Sweden)  Prevention of epileptogenesis - a realistic goal? - Astrid Nehlig (France)  Prevention of epileptogenesis - can currently available antiepileptic drugs have a role? - Simon Shorvon (UK)  Prevention of adverse effects of antiepileptic drug treatment - Emilio Perucca (Italy)  Prevention of epilepsy-related mortality - Torbjörn Tomson (Sweden)  Prevention of stigma - Ann Jacoby (UK)

EPILEPSY ADVOCACY EUROPE SYMPOSIUM: A POLITICAL AGENDA FOR SUPPORTING EPILEPSY CARE AND RESEARCH IN EUROPE Chair: TBC  The ILAE-IBE roadmap in advocating for epilepsy care and research - TBC  A summary of the epilepsy projects financed by Framework Programme 7 - TBC  An update on initiatives at national level - TBC

COMMISSION ON EUROPEAN AFFAIRS (CEA) SYMPOSIUM: REGULATORY ISSUES WITH ANTIEPILEPTIC DRUGS: A EUROPEAN PERSPECTIVE Chair: Michel Baulac (France)  Challenges with the monotherapy indication - Emilio Perucca (Italy)  Added value of a new AED: are head-to-head, add-on, comparative studies feasible? - Michel Baulac (France)  Extrapolation of efficacy data from adults to children: the paediatric viewpoint - Alexis Arzimanoglou (France)  The EMA and the European regulatory network - TBC



2nd JOINT CEA - ESRS (EUROPEAN SLEEP RESEARCH SOCIETY) SYMPOSIUM: EPILEPTIC AND NON-EPILEPTIC SLEEP-RELATED PAROXYSMAL MOTOR EVENTS Co-Chairs: Lino Nobili (Italy), Sofia Eriksson (UK)  Pathophysiologic interrelationship between sleep mechanisms and nocturnal focal seizures - Florin Amzica (Canada)  Neural networks in sleep-related complex motor seizures - Philippe Kahane (France)  Non epileptic complex motor behaviours - Claudio Bassetti (Switzerland)  Sleep-related epilepsy and comorbidity with sleep disorders - Raffaele Manni (Italy)

ILAE CLASSIFICATION IN CLINICAL PRACTICE A case based interactive session designed to illustrate the place of classification in day-to-day practice. Co-Chairs: Helen Cross (UK), Sameer Zuberi (UK)  Overview - where are we now? - Helen Cross (UK)  Epileptic spasms - a clinical dilemma - Christian Korff (Switzerland)  Focal seizures, descriptors and aetiology - Edouard Hirsch (France)  Syndromology: age doesn’t matter - Carla Marini (Italy)

NEUROBIOLOGY SYMPOSIUM The programme of this symposium is currently being prepared by the ILAE Commission on Neurobiology and will be later announced on the congress website.



MAIN SESSIONS PHARMACOLOGY PHARMACOTHERAPY OF THE FUTURE: NEW MOLECULES, NEW TARGETS, NEW GOALS This main session will be devoted to the pharmacotherapy of the future, with the aim to discuss new molecular targets and treatment goals, including the far reaching objective of antiepileptogenesis, but also the more immediate clinical potential of existing drugs of interest, such as ketamine, bumetamide and serotoninergic agents. Co-Chairs: Philippe Ryvlin (France), Elinor Ben-Menachem (Sweden)  Novel molecular targets in epileptogenesis - Asla Pitkänen (Finland)  Modulating the NMDA receptor with ketamine - Matthew Walker (UK)  Modulating serotonin in epilepsy: why and how? - TBC  Bumetamide in humans: what is the current evidence? - Eugen Trinka (Austria)

PAEDIATRICS EPILEPSY SYNDROMES: FROM INFANCY TO ADULTHOOD The session will focus on the analysis of the similarities and differences between paediatric and adult epileptic syndromes. Invited speakers will present the clinical and neurophysiological aspects and the prognostic value of several types of seizures associated with idiopathic or symptomatic epileptic syndromes, and their different significance in the light of the variations they go through between age at onset and adulthood. The influence of genetic mutation, type and frequency of seizures and treatment on long-term cognitive and motor evolution will be stressed. Co-Chairs: Federico Vigevano (Italy), Thanos Covanis (Greece)  Idiopathic generalized epilepsies: overlap and differences - Paolo Tinuper (Italy)  Idiopathic focal epilepsies: overlap and differences - Ulrich Stephani (Germany)  Temporal lobe epilepsy: how the age influences the syndrome - Andras Fogarasi (Hungary)  Dravet Syndrome: from infancy to adulthood - Ingrid Scheffer (Australia)

BASIC SCIENCE CHANGING EPILEPTIC BRAIN: TRANSLATIONAL CHALLENGES AND OPPORTUNITIES Some of the main challenges of current epileptology is to strengthen translational aspects of basic and preclinical research and to bring discoveries in labs to bedside. This session is an attempt to tackle these challenges by first highlighting the critical points that need to be addressed, in order to promote translational epilepsy research, followed by topics on gene therapy, inflammation and epigenetic approaches, which hold high hopes of becoming clinically applicable alternative therapeutics for epilepsy in the future. Chair: Merab Kokaia (Sweden)  How to make basic research translational - Michele Simonato (Italy)  Novel perspectives in gene therapy translation - Dimitri Kullmann (UK)  Translating inflammation into therapy - Annamaria Vezzani (Italy)  Epigenetics and master regulators in translation - David Henshall (Ireland)



SURGERY WHO BENEFITS FROM EPILEPSY SURGERY? Surgical treatment for epilepsy is major brain surgery. As such, it is not a decision to undertake lightly, but one to be carefully considered. Not everyone with epilepsy can benefit from a surgical procedure. The medical team needs to help the patient and their family understand the complications and outcomes of epilepsy surgery in the context of the risk of uncontrolled seizures and high doses of medications. This main session offers a critical overview of risks and benefits of current epilepsy surgery, discusses what is acceptable risk and gives advice for counselling and rehabilitation. Co-Chairs: Reetta Kälviäinen (Finland), Philippe Kahane (France)  Why do patients risk brain surgery for epilepsy? - Kristina Malmgren (Sweden)  What do we know about long-term seizure outcomes in adults and children? - John Duncan (UK)  How well can we predict individual risks and benefits? - Arto Immonen (Finland)  How can we help patients to a better life after epilepsy surgery? - Sarah Wilson (Australia)

SESSIONS PHARMACOLOGY DIFFERENT APPROACHES TO DESIGN AND EARLY ASSESSMENT OF NEW ANTIEPILEPTIC DRUGS Co-Chairs: Svein I. Johannessen (Norway), Dorothee Kasteleijn-Nolst Trenité (The Netherlands)  Animal model-based design of new antiepileptic drugs - Steve White (USA)  Pharmacokinetic-based design of new antiepileptic drugs that are follow-up compounds to existing drugs - Meir Bialer (Israel)  Mechanism-based design of new antiepileptic drugs - Wolfgang Löscher (Germany)  Proof of concept studies in assessment of new antiepileptic drugs - Christian E. Elger (Germany)

CARBAMAZEPINE 50TH ANNIVERSARY SYMPOSIUM (1964-2014) Co-Chairs: Günter Krämer (Switzerland), Dana Craiu (Romania)  How carbamazepine came to dominate the epilepsy world - Simon Shorvon (UK)  How carbamazepine structure and clinical experience affected the design of oxcarbazepine and eslicarbazepine acetate - Meir Bialer (Israel)  Pharmacology and clinical therapeutics of carbamazepine and its progeny - Eugen Trinka (Austria)  How does enzyme induction impact carbamazepine’s current and future position in epilepsy therapy? - Martin Brodie (UK)



WITHDRAWAL OF ANTIEPILEPTIC DRUGS - POSSIBILITIES AND CONSEQUENCES Co-Chairs: Leif Gjerstad (Norway), Miri Neufeld (Israel)  Risk of relapse and possible predictors for successful withdrawal of antiepileptic drugs - Morten I. Lossius (Norway)  Timing of withdrawal of antiepileptic drugs after surgery - Kees Braun (The Netherlands)  Possible benefits of antiepileptic drugs withdrawal on cognition - Christoph Helmstaedter (Germany)  Refractory seizures after antiepileptic drugs withdrawal - Tony Marson (UK)

CONTROVERSIAL ISSUES IN THE MANAGEMENT OF WOMEN WITH EPILEPSY CONTEMPLATING PREGNANCY Co-Chairs: Jana Zarubova (Czech Republic), Anne Sabers (Denmark)  Are there situations where a woman may decide not to become pregnant because of her epilepsy? - Lina Nashef (UK)  Treatment alternatives for women with idiopathic generalized epilepsies contemplating pregnancy - Dina Battino (Italy)  Antiepileptic drugs level monitoring during pregnancy: is it useful? - Torbjörn Tomson (Sweden)  Folate supplementation - uncertainties? - Dick Lindhout (The Netherlands)

PAEDIATRICS TARGETED APPROACHES IN CHILDHOOD EPILEPSY Co-Chairs: Renzo Guerrini (Italy), Maria Dahlin (Sweden)  Diet treatments - mechanisms of action - Simon Heales (UK)  Ketogenic diet: indications and long-term results - Tove Hallböök (Sweden)  mTOR inhibitors: efficacy on epilepsy in tuberous sclerosis patients - Paolo Curatolo (Italy)  Early treatment with vigabatrin in tuberous sclerosis: do we affect outcome? - Sergiusz Jozwiak (Poland)

NEW INSIGHTS IN EPILEPSY GENETICS Co-Chairs: Norman Delanty (Ireland), Anna-Elina Lehesjoki (Finland)  Paediatric genetic epilepsies with focal seizures: PRRT2 and infantile convulsions and choreoathetosis - Ingrid Scheffer (Australia)  Genetic epileptic encephalopathies - Rima Nabbout (France)  Genetic variants predisposing to idiopathic generalized epilepsies - Holger Lerche (Germany)  Common variants affecting treatment response in epilepsy - Sanjay Sisodiya (UK)



NEW INSIGHTS IN EPILEPTIC ENCEPHALOPATHIES Co-Chairs: Solomon Moshé (USA), Alexis Arzimanoglou (France)  Epileptic encephalopathy versus encephalopathy with epilepsy - Nicola Specchio (Italy)  What do animal studies teach us? - Martin Holtkamp (Germany)  The role of epileptiform activity during sleep - Maria Peltola (Finland)  From diagnosis to therapeutic approach - Colin Ferrie (UK)

UNVERRICHT-LUNDBORG DISEASE FROM 1891 TO 2014 Co-Chairs: Sulev Haldre (Estonia), Ruta Mameniškiene (Lithuania)  Herman Lundborg: his research and contributions - Peter Mattsson (Sweden)  Lessons learned from genetic studies of Unverricht-Lundborg disease - Anna-Elina Lehesjoki (Finland)  Unverricht–Lundborg disease: genotype and phenotypes - Reetta Kälviäinen (Finland)  Medical management of Unverricht–Lundborg disease today - Pierre Genton (France)

BASIC SCIENCE DECIPHERING EPIGENETIC MECHANISMS OF EPILEPTOGENESIS Co-Chairs: Ingmar Blümke (Germany), Christophe Bernard (France)  Epileptogenesis-related genomic DNA methylation in a rat status epilepticus model - Katja Kobow (Germany)  Epileptogenesis-related genomic DNA methylation in a rat acquired epilepsy model: similar rather than different? - Katarzyna Lukasiuk (Poland)  Analysis of epigenetic factors for excitability in human epileptic tissue - Albert Becker (Germany)  Altered expression of histone deacetylases in a mouse mode of TLE - Günther Sperk (Austria)

TRANSLATIONAL BIOMARKERS AND TARGETS FOR EPILEPTOGENESIS Co-Chairs: Annamaria Vezzani (Italy), Natalia Gulyaeva (Russia)  MRI biomarkers for post-traumatic epileptogenesis - Asla Pitkänen (Finland)  PET imaging in models of epileptogenesis and chronic epilepsy - Stefanie Dedeurwaerdere (Belgium)  Imaging blood-brain barrier dysfunction as a biomarker for epileptogenesis - Alon Friedman (Israel)  Crosstalk between biomarker and treatment target identification: from experimental models to human epileptogenesis - Albert Becker (Germany)



ROLE OF GLIA IN EPILEPTOGENESIS Co-Chairs: Uwe Heinemann (Germany), Erik Taubøll (Norway)  Age-related impairment of neuron-glia interactions in rats with epilepsy - Astrid Nehlig (France)  Astrocytic activity in the age-dependent development of spike-and-wave discharges in genetic absence epilepsy rats - Filiz Onat (Turkey)  Crucial role of impaired astrocyte gap junction coupling in epilepsy - Christian Steinhäuser (Germany)  Roles of the glial water channel AQP4 and the potassium channel Kir4.1 in epilepsy - Kjell Heuser (Norway)

ILLUMINATING EPILEPTIC BRAIN Co-Chairs: Dimitri Kullmann (UK), Rüdiger Kohling (Germany)  Optogenetic tools to control brain activity: translational overview - Karl Deisseroth (USA)  Thalamic enlightening controls seizures - John Huguenard (USA)  Optogenetic regulation of epileptoform activity - Matthew Walker (UK)  Disrupting hypersynchronizations by optogenetics: activation of inhibitory interneurons - Merab Kokaia (Sweden)

SURGERY THE DOWNSIDES OF EPILEPSY SURGERY Chair: Cigdem Özkara (Turkey)  Surgical and neurological complications of epilepsy surgery - Bertil Rydenhag (Sweden)  Surgically-induced behavioural change - Simon Shorvon (UK)  The consequences to patients of surgically-induced memory disturbance - Sallie Baxendale (UK)  MRI negative neocortical epilepsy - the mythology of a ‘seizure focus’ - Paul Boon (Belgium)

SINGLE PULSE STIMULATION IN PRESURGICAL ASSESSMENT OF EPILEPSY Co-Chairs: Gonzalo Alarcon (UK), Andrea Rossetti (Switzerland)  Responses to intracranial single pulse electrical stimulation: clinical and pathophysiological significance - Antonio Valentin (UK)  Cortico-cortical evoked potentials: The Cleveland Clinic experience - Rei Enatsu (USA)  Single pulse electrical stimulation and high frequency oscillations - Maryse Von Klooster (The Netherlands)  Non-invasive alternatives: transcranial magnetic stimulation - Vasilios Kimiskidis (Greece)



EPILEPSY SURGERY IN GENETIC EPILEPSIES: IS IT FEASIBLE? Co-Chairs: José M. Serratosa (Spain), Petia Dimova (Bulgaria)  Epilepsy surgery in familial temporal lobe epilepsy - Fernando Cendes (Brazil)  Epilepsy surgery in autosomal dominant nocturnal frontal lobe epilepsy - Paolo Tinuper (Italy)  Epilepsy surgery in tuberous sclerosis - Floor E. Jansen (The Netherlands)  Epilepsy surgery in partial forms of GEFS plus - Helen Cross (UK)

CALLOSOTOMY: PAST, PRESENT AND FUTURE Chair: Eija Gaily (Finland)  Indication for callosotomy and long-term outcome - Ingrid Olsson (Sweden)  Surgical procedures and functional aspects - Bertil Rydenhag (Sweden)  The functional anatomy of fibre crossing - Mojtaba Zarei (Iran)  A reappraisal of the disconnection syndromes - Marco Catani (UK)

OTHER CATEGORIES WHAT MORE SHOULD WE DO? REHABILITATION IN EPILEPSY Chair: Sarah Wilson (Australia)  Rehabilitation in epilepsy - too little too late? - Lena Nilsson (Sweden)  Employment and epilepsy - vocational rehabilitation - Ulrich Specht (Germany)  Cognitive deficits in epilepsy - rehabilitation interventions - TBC  Rehabilitation after epilepsy surgery - what is needed and what can be achieved? - Margarete Pfäfflin (Germany)

SUDDEN UNEXPECTED DEATH IN EPILEPSY: FROM NEW INSIGHTS INTO MECHANISMS TO PREVENTION OPPORTUNITIES Chair: Rainer Surges (Germany)  Neurobiology of Sudden Unexpected Death in Epilepsy - basis for identification of patients at risk and for interventions - Jeff Noebels (USA)  From unwitnessed fatality to witnessed rescue: non-pharmacological intervention - Lina Nashef (UK)  From unwitnessed fatality to witnessed rescue: pharmacological intervention - Philippe Ryvlin (France)  Epidemiology of Sudden Unexpected Death in Epilepsy prevention: how to test simple populationbased interventions - Leone Ridsdale (UK)



SEIZURE DETECTION, SEIZURE COUNTING - METHODS TO IMPROVE ACCURACY Co-Chairs: Andrea Rossetti (Switzerland), Stevo Lukic (Serbia)  How reliably do patients count seizures: behind the mystery of the patient’s diary? - Christian Hoppe (Germany)  How reliable is surface-EEG? - Christoph Baumgartner (Austria)  Seizure detection and quantification using surface EMG and accelerometry - Sándor Beniczky (Denmark)  Seizure detection and quantification by heart rate variability monitoring - Guido Rubboli (Denmark)

IMPROVING YIELD AND SAFETY IN THE EPILEPSY MONITORING UNIT Co-Chairs: Kristina Källén (Sweden), Guido Rubboli (Denmark)  General safety issues in the Epilepsy Monitoring Unit - Judith Dobesberger (Austria)  Antiepileptic drugs tapering or withdrawal for seizure provocation: recommendations and safety issues - Stevens Claus (The Netherlands)  Risks with invasive monitoring - can we improve damage control? - Andrew McEvoy (UK)  Epilepsy Monitoring Unit organization, intensity of monitoring and patient management during seizures: how to improve diagnostic yields - Sándor Beniczky (Denmark)

ADVANCES IN EEG AND IMAGING FOR LOCALIZATION OF EPILEPTOGENIC FOCI Co-Chairs: Roland Flink (Sweden), Christoph Baumgartner (Austria)  High density EEG source imaging - Margitta Seeck (Switzerland)  High frequency oscillations (HFO) - what does it mean and how useful is it? - Julia Jacobs (Germany)  EEG combined with fMRI - recording in the scanner - clinical application? - TBC  Sophisticated PET-imaging and new tracers in epileptology - TBC

AUTOIMMUNE EPILEPSY Co-Chairs: Jukka Peltola (Finland), Eva Kumlien (Sweden)  Glutamate receptor antibodies against AMPA and NMDA receptors are present in epilepsy patients, kill neurons and damage the brain - Mia Levite (Israel)  NMDA and GABA(B)-receptor antibodies in encephalitis: occurrence and pathogenic mechanisms - Marteen Titulaer (The Netherlands)  Autoantibodies associated with epilepsy and other CNS disorders: new developments and future challenges - Angela Vincent (UK)  Treatment options for autoimmune epilepsy - Christian Bien (Germany)



EPIDEMIOLOGY OF EPILEPSY: FROM FUNDAMENTALS TO FUTURE CONTRIBUTIONS Co-Chairs: Lars Forsgren (Sweden), Ley Sander (UK)  Epilepsy epidemiology in the era of new ILAE definitions and organizations of seizures and epilepsy - Ettore Beghi (Italy)  What have we learned from epidemiology on etiologies and comorbidities of epilepsy? - Dale Hesdorffer (USA)  New insights into the prognosis of epilepsy - Aidan Neligan (UK)  How can the nationwide patient registries be utilized to advance our understanding of epilepsy and its consequences? - Jakob Christensen (Denmark)

EMOTION RECOGNITION AND SOCIAL COGNITION IN TEMPORAL LOBE EPILEPSY Co-Chairs: Petr Marusic (Czech Republic), Hrvoje Hecimovic (Croatia)  Facial emotion recognition in temporal lobe epilepsy patients - Stefano Meletti (Italy)  Social cognition in temporal lobe epilepsy patients - Henric Jokeit (Switzerland)  Social cognition in children with epilepsy - Mary Lou Smith (Canada)  Postoperative changes in emotional recognition and social cognition in temporal lobe epilepsy patients - Jana Amlerova (Czech Republic)

SOMATIC COMORBIDITY IN EPILEPSY Chair: Dale Hesdorffer (USA)  Concepts, importance and examples of somatic comorbidity in general - Raoul Hennekam (The Netherlands)  Genetics of somatic comorbidities - Sanjay Sisodiya (UK)  Epilepsy and cancer - Ley Sander (UK)  Obesity: occurrence in epilepsy and treatment implications - Alla Guekht (Russia)

THE MICHAEL DEBATE: FOCAL ICTOGENESIS Chair: Peter Wolf (Denmark)  Cortical dysplasia is never focal - Ingmar Blümcke (Germany)  Ictogenesis in idiopathic “focal” epilepsies - Matthias Koepp (UK)  The syndrome of temporal lobe epilepsy reflects widespread network dysfunction - Jean Gotman (Canada)  Are there more intelligent invasive treatment options for focal epilepsies beyond resections? - Christian E. Elger (Germany)



TEACHING SESSIONS WHAT NOT-TO-DO IN EPILEPSY Are you interested to find out what can go wrong in the management of epilepsy and how to avoid it? Join us in our interactive morning seminars. We know all about mistakes, including our own!

Co-Chairs: Dieter Schmidt (Germany), Christian E. Elger (Germany)  DAY 1 Red flags in the semiology of epileptic seizures Is it epilepsy? Which type of epilepsy? - Christian E. Elger Is it a non-epileptic attack? - Dieter Schmidt  DAY 2 Red flags for diagnosis of epilepsy How to miss the diagnosis of epilepsy - Dieter Schmidt How to mishandle diagnostic tests such as EEG and MRI - Christian E. Elger  DAY 3 Red flags: time for antiepileptic drugs and time for surgery How to miss the best time to start or to stop antiepileptic drugs - Dieter Schmidt How to miss the best time for surgery - Christian E. Elger

FOUND IN TRANSLATION, BASIC SCIENCE EXPLAINED Coordinator: Merab Kokaia (Sweden) The main goal of this series of teaching sessions is to provide a common platform for meetings and discussions of basic scientists and clinical neurologists, where topics of basic research will be addressed from a translational perspective. The presentations are designed in a more educational format directed towards clinical neurologists to fill the gap and increase mutual understanding in fundamental concepts for novel treatment strategies that are currently emerging.  DAY 1 Translational models of epileptogenesis Chair: Wolfgang Löscher (Germany) Epilepsy developing after status epilepticus - Astrid Nehlig (France) Epilepsy developing after traumatic brain injury and stroke - Asla Pitkänen (Finland) Epilepsy developing in genetic models - Antoine Depaulis (France)



 DAY 2 Understanding epileptogenesis on synaptic level Co-Chairs: Christine Ekdahl Clementson (Sweden), My Andersson (Sweden) Presynaptic remodeling and epilepsy - Sari Lauri (Finland) Inhibitory synaptic remodeling - Rosa Cossart (France) Plasticity at the axonal initial segment - Hansjürgen Volkmer (Germany)  DAY 3 The role of mitochondria and reactive oxygen species in epileptogenesis - from bench to bedside Chair: Matthew Walker (UK) Mitochondria, reactive oxygen species and epilepsy - potential treatment strategies - Stjepana Kovac (UK) Mitochondrial involvement in temporal lobe epilepsy - Wolfram S. Kunz (Germany) Mitochondrial encephalopathies in childhood epilepsy: current and potential drug targets - TBC

SEIZURE SEMIOLOGY SMÖRGÅSBORD The sessions will be interactive with open discussions following each video-EEG demonstration. The learning goals are that participants should be able to:  correlate seizure-related symptoms to anatomical brain areas and structures  analyse localizing and lateralizing signs during seizure evolution  identify patients suitable for referral to a tertiary epilepsy centre with a surgical programme Co-Chairs: Kristina Källén (Sweden), Roland Flink (Sweden)  DAY 1 Classification of seizures and their anatomical correlates. What have we learned from functional brain stimulation, SISCOM and fMRI?  DAY 2 Analysis of seizure evolution. Localizing and lateralizing signs from focal onset to generalization and during the postictal period. How reliable are they?  DAY 3 Seizure semiology in surgical candidates. Selected patients from the National Swedish Epilepsy Surgery Registry are demonstrated with reports of outcome from different surgical procedures and histological pathology.

ABC OF EPILEPSY EPIDEMIOLOGY Coordinators and speakers: Dale Hesdorffer (USA), Ley Sander (UK) The purpose of the existing standards for the conduct of epidemiological studies and surveillance of epilepsy is to describe epidemiological methodology for new investigators, to provide definitions and to propose new tools that address the broader scope of epidemiological research in epilepsy. These topics will be discussed in a 90-minute teaching session designed for people interested in initiating epidemiological studies of epilepsy as well as for those who want to be able to interpret epidemiological publications. Examples will be provided for low and middle income countries as well as upper middle and high income countries.



VIREPA AT WORK It is ten years since ILAE/CEA distance education was introduced, initially under the wings of 'EUREPA', and, since 2009, as a formal part of the ILAE educational programme run by the ILAE Virtual Epilepsy Academy 'VIREPA'. What started as a single course on the genetics of epilepsy has developed into an extensive programme: in 2014 VIREPA offers courses on EEG, imaging, clinical therapy, genetics, sleep and psychiatric aspects of epilepsy. New courses are in development. What remains as constant is an emphasis on small scale group work and a high level of interactive work, both between students and tutors and between students themselves. The early morning courses in Stockholm will bring together tutors and former pupils of the EEG and imaging courses and will show, based on case presentations, how the VIREPA format works in practice. Chair: Walter van Emde Boas (The Netherlands) DAY 1 EEG in the diagnosis and management of epilepsy DAY 2 Neuroimaging

TEACHING COURSES PHARMACOLOGICAL TREATMENT OF EPILEPSY The target of this course is anyone interested in the pharmacological treatment of epilepsy. The course covers the spectrum from basic pharmacology and pharmacokinetics to clinical trials and practical use of antiepileptic drugs in different populations and situations.

Chair: Svein I. Johannessen (Norway) PART 1: Basic and pharmacokinetic aspects  Mechanisms of action of antiepileptic drugs - Wolfgang Löscher (Germany)  Do mechanisms of action matter for efficacy, tolerability and antiepileptic drugs selection? - Graeme Sills (UK)  Clinical pharmacokinetics of antiepileptic drugs - Cecilie Johannessen Landmark (Norway)  Drug interactions and clinical management of pharmacokinetic variabilty - Philip Patsalos (UK) PART 2: Clinical aspects  Strategies in the development of new antiepileptic drugs - what is in the pipeline? - Meir Bialer (Israel)  Critical reading of clinical trials of antiepileptic drugs - Bernd Schmidt (Germany)  Antiepileptic drugs selection: from evidence-based guidelines to clinical practice: children - Helen Cross (UK)  Antiepileptic drugs selection: from evidence-based guidelines to clinical practice: adults and the elderly - Elinor Ben-Menachem (Sweden)  Predicting, preventing and managing adverse effects of antiepileptic drugs - Piero Perucca (Italy)



   

Pregnancy and breast-feeding - Torbjörn Tomson (Sweden) Medical management of difficult-to-treat patients - TBC Termination of antiepileptic drugs treatment in patients in remission - Morten Lossius (Norway) Update on the treatment of status epilepticus - Eugen Trinka (Austria)

THE ROLE OF THE EPILEPSY NURSE IN THE MANAGEMENT OF PEOPLE WITH EPILEPSY Speakers: TBC  The role of the epilepsy specialist nurse in the multidisciplinary epilepsy team  Efficacy of educational programmes for children, adolescents and adults with epilepsy  Structured, nurse-led intervention programme improves quality of life in patients with epilepsy  Implementation of guidelines for epilepsy diagnosis and treatment by the epilepsy nurse

TEACHING COURSE FOR EEG TECHNICIANS: VIDEO EEG MONITORING The session will discuss more advanced EEG techniques, analysis and monitoring strategies within the diagnostic and preoperative epilepsy programmes. Some basic knowledge about EEG recordings is an advantage for the participants but anyone with an interest in EEG monitoring is welcome.

Speakers: Florin Amzica (Canada), Sándor Beniczky (Denmark), Roland Flink (Sweden) Topics that will be addressed:  electrodes used for monitoring; sphenoidals vs “low-row”, high density EEG  seizure detection  automatic spike detection  basic source analysis  reporting the findings (semiology and ictal EEG)

Information in this announcement may be subject to change. Please check for all updates.



AWARDS EUROPEAN EPILEPTOLOGY AWARD (EEA) 2014 The Commission on European Affairs (CEA) wishes to invite nominations for the European Epileptology Award 2014. The award will be presented to a European epileptologist in recognition of his or her outstanding contribution to European epileptology at a special symposium during the 11th European Congress on Epileptology in Stockholm in 2014. The CEA will contribute 10,000 EUR to the award and a committee specially selected by the CEA will judge the nominations and select the recipient. Any European individual who has made a substantial lifetime contribution in any aspect of epileptology is eligible for nomination. The major part of the candidate’s work should have taken place in Europe. Nominations will be accepted from European ILAE Chapters, institutions or individuals. Please note that self-nomination is not permitted. EUROPEAN EPILEPSY EDUCATION AWARD The award carries no monetary value but is given in recognition of outstanding contributions to European epilepsy education. The award consists of a diploma and will be announced in conjunction with the European Congress on Epileptology to which the awardee will have their registration fees waived. Awards will be made no more than once every two years and to a maximum of one awardee on each occasion. Eligible are individuals in Europe of any profession who have made an outstanding contribution to the advancement of epilepsy education on a European level and who have not received so far an Ambassador for Epilepsy Award or the European Epileptology Award.. Nominations will be accepted from European ILAE Chapters, institutions or individuals. Please note that selfnomination is not permitted. The CEA will evaluate the nominations and select the awardees. YOUNG INVESTIGATOR AWARDS The awards carry no monetary value but are given in recognition of outstanding contributions to epilepsy research and in order to stimulate a promising research career in epileptology. The awards consist of a diploma and will be announced in conjunction with the European Congress on Epileptology to which the awardees will have their registration fees waived. Awards will be made no more than once every two years and to a maximum of two awardees, one in basic science and one in clinical science on each occasion.



Eligible are researchers in Europe under the age of 45 who have made a substantial scientific contribution and with a documented exceptionally promising career in epilepsy research. Nominations will be accepted from European ILAE Chapters, institutions or individuals. Please note that selfnomination is not permitted. The CEA will evaluate the nominations and select the awardees. EUROPEAN EPILEPSY SERVICE AWARDS The awards carry no monetary value but are given in recognition of outstanding service contributions to European Epileptology. The awards consist of a diploma and will be announced in conjunction with the European Congress on Epileptology to which the awardees will have the registration fee waived. Awards will be made no more than once every two years and to a maximum of two awardees, one in basic science and one in clinical science on every occasion. Nominations will be accepted from European ILAE Chapters, institutions or individuals. Please note that selfnomination is not permitted. The CEA will evaluate the nominations and select the awardees.

NOMINATION INSTRUCTIONS Please complete one nomination form for each nominee (the form is available on the congress website). A person who received the ILAE-IBE Ambassador for Epilepsy Award cannot be a candidate for any of the above three awards. Completed nomination forms should be accompanied by: 1. A Curriculum Vitae of the nominee (400 - 800 words). 2. An explanatory statement outlining the reasons the proposed nominee has been nominated for the award. This should include an assessment of the nominee's professional achievements as well as his/her contribution to European developments in epileptology (max. 400 words). 3. A list of up to 10 publications considered to be particularly representative of the nominee’s contributions. Nomination forms and other documentation should be returned by December 31st 2013 to or posted to: ILAE Congress Secretariat 7 Priory Hall Blackrock Co. Dublin Ireland



GENERAL INFORMATION TRAVEL BURSARIES In an effort to further encourage Young Investigators (under 45 years of age) to participate in the 11th European Congress on Epileptology, the Commission on European Affairs (CEA) will award travel bursaries to a number of young applicants to assist with registration, travel and accommodation expenses. Members of the Bursary Sub-Commission will select the successful applicants. Details of how to apply for a travel bursary will be announced on the congress website at ABSTRACT SUBMISSION All abstracts should be submitted via the congress website at from November 2013. The abstract submission deadline is currently set for January 2014. Abstracts must be submitted in English, ready for immediate publication, in keeping with submission guidelines. Authors will receive an e-mail acknowledgement on receipt of their abstract. Authors whose abstracts are accepted must register following notification of this acceptance. Late abstracts will not be accepted. CONTINUING MEDICAL EDUCATION (CME) CREDITS The 11th European Congress on Epileptology has applied to the European Accreditation Council for Continuing Medical Education (EACCME) for CME accreditation. The EACCME is an institution of the European Union of Medical Specialists (UEMS). Please visit for further information. EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA). For further details, please visit Please check the congress website for updates on CME accreditation.



VENUE Stockholmsmässan Mässvägen 1 125 30 ÄLVSJÖ Phone +46 8 749 41 00 Fax +46 8 99 20 44 Website:

CONGRESS DATES 29th June to 3rd July 2014

CONGRESS WEBSITE All details regarding the congress will be announced on the congress website as they become available. Abstract submission, registration and bursary applications will be processed online. Please refer to the website for scientific programme updates. Details on other ILAE epilepsy congresses worldwide can be accessed through the epilepsy congress portal site at

DATES FOR YOUR DIARY On-line registration available

Mid 2013

Abstract submission and travel bursary application available

November 2013

Abstract submission and travel bursary application deadline

January 2014

REGISTRATION Registration is available online at Early registration deadline

End March 2014

Late registration deadline

Mid May 2014

Last minute registration deadline

Mid June 2014

Further information regarding registration terms and conditions and cancellation policies may also be found on the website.



USEFUL CONGRESS INFORMATION Language The official language of the 11th European Congress on Epileptology will be English. Congress Updates To receive regular newsletter with updates about the congress please submit your contact details via the congress website or contact Visas EU residents and US, Canadian, Australian, New Zealand and South African citizens do not require a visa and are permitted to enter the country with just a valid passport. Visitors from other countries should contact the Swedish embassy in their respective country for more information. Visitors arriving in Stockholm either by air connection or at a land border will generally not find customs clearance a complicated or stressful experience provided they are in compliance with Swedish customs. Liability and Insurance The congress organisers will not accept liability for personal injury or loss/damage to property/belongings of participants either before, during or following the congress or their stay in Stockholm. It is therefore recommended that participants arrange their own personal health, accident and travel insurance. Currency The currency in Sweden is the Swedish krona (crown) - SEK. Credit and debit cards are accepted almost everywhere in Stockholm. Accommodation Stockholm offers a wide range of excellent hotels in every price category. The accommodation agency Meetagain has been selected as the official accommodation agency for the 11th European Congress on Epileptology and has secured competitive rates on a selected list of hotels both for individuals and groups in Stockholm city centre, with easy access to the congress venue Stockholmsmässan by public transport. Please refer to for more details. For accommodation enquiries, please contact: Meetagain Phone: +46 8 664 58 00 Cell phone: +46 70 929 85 00 E-mail:

The 11th ECE Congress Secretariat • Programme coordinator - Claire Derousseaux Email: •

Exhibition & sponsorship - Finola Quinn Email:

Group registration - Gus Egan Email:

Individual registration - Carla Glynn Email:


ILAE Congress Secretariat 7 Priory Hall Blackrock Co. Dublin Ireland Phone: +353 1 205 6720 Fax: + 353 1 205 6156


11th European Congress on Epileptology  

11th European Congress on Epileptology

Read more
Read more
Similar to
Popular now
Just for you